Pure Global

INFLIXIMAB (IFX) - ANVISA Registration 80102511760

Access comprehensive regulatory information for INFLIXIMAB (IFX) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102511760 and manufactured by BUHLMANN LABORATORIES AG. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS Mร‰DICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including IMMUNDIAGNOSTIK AG, PROGENIKA BIOPHARMA S.L., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
4 Competitors
4 Recent Registrations
80102511760
Registration Details
ANVISA Registration Number: 80102511760
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Quantum Blueยฎ Infliximab
Risk Class II

Registration Details

80102511760

25351580029201604

04718143000194

Company Information

Switzerland
PT: SUรร‡A

Dates and Status

Mar 27, 2017

VIGENTE

09/18/2025 19:00:01